Nicholas Abidi, MD
Foot and Ankle Surgery · Capitola, CANPI 1548273758
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $91,860 of the $116,560 with a category attached, or 78.8%. Arthrex accounts for 78.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $37,296 and has fallen 90.9% since, to $3,380 in 2025. Among foot and ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $733.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$92K
- Acumed LLC$10K
- Zimmer Biomet$3K
- Stryker$3K
- Omnilife Science, Inc$3K
- Heraeus Medical, LLC.$2K
- plus $4K from 19 others
Across 14 payments — averaging $2639.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$37K
What the payments were for
- Royalty or licence$91,86079%
- Consulting fees$14,20012%
- Speaking & faculty fees$1,2001%
- Travel & lodging$2,7362%
- Food & beverage$5,7605%
- Education$8051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 19 | $91,935 |
| Acumed LLC | 20 | $10,106 |
| Zimmer Biomet | 30 | $3,176 |
| Stryker | 32 | $2,877 |
| Omnilife Science, Inc | 13 | $2,657 |
| Heraeus Medical, LLC. | 3 | $1,967 |
| Exactech, Inc. | 5 | $1,945 |
| Evolution Surgical, Inc | 4 | $577 |
| Smith+Nephew | 8 | $339 |
| Bone Support Inc. | 1 | $250 |
| Globus Medical(2 entities) | 3 | $156 |
| Osiris Therapeutics Inc. | 2 | $143 |
| Johnson & Johnson(2 entities) | 6 | $130 |
| Fidia Pharma USA Inc. | 2 | $51 |
| Advita Ortho, LLC | 1 | $39 |
| Pacira Therapeutics, Inc. | 1 | $31 |
| Amgen | 1 | $29 |
| Orthofix Medical, Inc. | 1 | $25 |
| Vertex | 1 | $25 |
| Bioventus LLC | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Medtronic | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Vericel Corporation | 1 | $13 |
| Medshape, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$216,374
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS CFS$38,459
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE CFS$10,126
- Bone Graft Harvesting System$3,000
- Acutrak Headless Compression Screw System$2,610
- OMNIBotics 3.0$2,175
- PALACOS$1,922
- TRULIANT$1,750
- MAKO$1,452
- Fibula Rod System$1,200
- Small Fragment Base Set$1,200
- Persona$1,020
- EXACTECHGPS$1,000
- Oxford$696
- Cannulated Screw System$610
- Ankle Plating System$400
- Forefoot/Midfoot Plating System$400
- INFINITY$377
- ACUMED$330
- T2$328
How this compares
$116,560 in reported general payments places this provider in the 95th percentile of 1,126 foot and ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 65 | $5,449 |
| Famotidine | 42 | $285 |
| Gabapentin | 25 | $235 |
| Amoxicillin | 25 | $45 |
| Meloxicam | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Capitola
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
- Joseph ParkBurbank$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.